EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishing a novel mouse model of tacrolimus-induced post-transplant hepatocellular carcinoma pulmonary recurrence for transplant oncology

Jinliang Duan, Tao Chen, Shaofeng Chen, Zhenglu Wang, Lei Cao, Hong Zheng, Zhongyang Shen

Frontiers in Cell and Developmental Biology · 01.04.2026 · 14

DOI: 10.3389/fcell.2026.1796566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 01.04.2026. Verfasst von Jinliang Duan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nankai University School of Medicine, Tianjin, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-term immunosuppression following transplantation places recipients at a high risk of malignancy. Hepatocellular carcinoma (HCC) recurrence after transplantation poses significant challenges to long-term survival of recipients. Several studies in transplant oncology have established cancer-transplant models to support the development of therapies for reducing the risk of post-transplant cancer recurrence. However, existing models fail to recapitulate the complex immune status of recipients and the authentic tumor microenvironment after transplantation.

Methods

C57BL/6 recipient mice were injected intravenously with luciferase-expressing Hepa1-6 cells 7 days before receiving Balb/c cardiac allografts, followed by post-transplant immunosuppression with tacrolimus. On day 7 post-transplantation, the immune state of recipients was assessed by measuring serum inflammatory cytokines, and allograft rejection was evaluated by hematoxylin-eosin staining. Cancer progression was evaluated using in vivo imaging and measurements of serum alpha-fetoprotein levels, with subsequent histological confirmation.

Results

Allogeneic cardiac transplantation resulted in a significant increase in serum levels of pro-inflammatory cytokines accompanied by a marked reduction in cancer burden. Marked lymphocytic infiltration, hemorrhage, and structural disintegration were observed in the grafts of untreated animals. In contrast, tacrolimus treatment effectively attenuated both the inflammatory cytokine response and acute allograft rejection but, conversely, resulted in a significant increase in tumor burden. Histological analysis confirmed that malignancies were exclusively localized to the lungs, mirroring the most common site of clinical HCC recurrence post-transplantation.

Conclusion

This model effectively simulates the elevated risk of cancer recurrence under post-transplant immunosuppression and faithfully recapitulates lung metastasis of HCC mediated by circulating cancer cells—the most common site of clinical recurrence following liver transplantation for HCC. It thus provides a reliable tool for basic research aimed at reducing risk of post-transplant cancer recurrence.

Schlagwörter

Stichwörter der Autor:innen

allotransplantationcancer recurrencehepatocellular carcinomaimmunosuppressionmouse model

Autor:innen und Institutionen

  • Nankai University School of Medicine, Tianjin, China.
  • Tianjin Organ Transplantation Research Center, Tianjin First Central Hospital, Tianjin, China.
  • Biological Sample Resource Sharing Center, Tianjin First Central Hospital, Tianjin, China.
  • Institute of Transplantation Medicine, Nankai University, Tianjin, China.
  • Tianjin Key Laboratory of Organ Transplantation, Tianjin First Central Hospital, Tianjin, China.
  • Key Laboratory of Transplant Medicine, Chinese Academy of Medical Science, Tianjin, China.

Zitieren

APA

Duan, J., Chen, T., Chen, S., Wang, Z., Cao, L., Zheng, H., & Shen, Z. (2026). Establishing a novel mouse model of tacrolimus-induced post-transplant hepatocellular carcinoma pulmonary recurrence for transplant oncology. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1796566

Vancouver

Duan J, Chen T, Chen S, Wang Z, Cao L, Zheng H, et al. Establishing a novel mouse model of tacrolimus-induced post-transplant hepatocellular carcinoma pulmonary recurrence for transplant oncology. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1796566

BibTeX
@article{Duan2026,
  author = {Duan, Jinliang and Chen, Tao and Chen, Shaofeng and Wang, Zhenglu and Cao, Lei and Zheng, Hong and Shen, Zhongyang},
  title = {Establishing a novel mouse model of tacrolimus-induced post-transplant hepatocellular carcinoma pulmonary recurrence for transplant oncology},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1796566}
}
Kostenlos starten →